Mustang Bio
MBIO
MBIO
73 hedge funds and large institutions have $45.9M invested in Mustang Bio in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+9
Holders Change %
+14.06%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
27
Reduced
10
Closed
7
Calls
$147K
Puts
$334K
Net Calls
-$187K
Net Calls Change
-$65K
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$6.15M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
$2.44M |
| 3 |
Millennium Management
New York
|
$2.52M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
$1.24M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
$1.18M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$0 |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
$137K |
| 3 |
Renaissance Technologies
New York
|
$2.41M |
| 4 |
BlackRock
New York
|
$6.1M |
| 5 |
Squarepoint
New York
|
$164K |
